1,3-Dimethylbutylamine
1,3-Dimethylbutylamine (1,3-DMBA, dimethylbutylamine, DMBA, 4-amino-2-methylpentane, or AMP), is a stimulant drug structurally related to methylhexanamine where a butyl group replaces the pentyl group. The compound is an aliphatic amine.
| |||
Names | |||
---|---|---|---|
Preferred IUPAC name
4-Methylpentan-2-amine | |||
Other names
(4-Methylpentan-2-yl)amine | |||
Identifiers | |||
3D model (JSmol) |
|||
ChemSpider | |||
ECHA InfoCard | 100.003.227 | ||
PubChem CID |
|||
UNII | |||
CompTox Dashboard (EPA) |
|||
| |||
| |||
Properties | |||
C6H15N | |||
Molar mass | 101.193 g·mol−1 | ||
Density | 0.717 g/mL[1] | ||
Boiling point | 108–110 °C (226–230 °F; 381–383 K)[1] | ||
Hazards | |||
NFPA 704 (fire diamond) | |||
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |||
Infobox references | |||
The hydrochloride and citrate salts of DMBA has been identified as unapproved ingredients in some over-the-counter dietary supplements,[2][3][4] in which it is used in an apparent attempt to circumvent bans on methylhexanamine.[5] The U.S. Food and Drug Administration (FDA) considers any dietary supplement containing DMBA to be "adulterated".[6] Despite the FDA's opposition, DMBA continues to be sold in the US.[7]
There are no known human safety studies on DMBA and its health effects are entirely unknown.[2][3][8]
References
- "1,3-Dimethylbutylamine". Sigma-Aldrich.
- Cohen, Pieter A.; Travis, John C.; Venhuis, Bastiaan J. (2015). "A synthetic stimulant never tested in humans, 1,3-dimethylbutylamine (DMBA), is identified in multiple dietary supplements". Drug Testing and Analysis. 7 (1): 83–7. doi:10.1002/dta.1735. PMID 25293509.
- "Unapproved Synthetic Stimulant "DMBA" Found in Multiple Dietary Supplements". NSF International. Archived from the original on 2016-11-22. Retrieved 2015-03-21.
- "FDA Warns 14 Sports Supplement Companies Of Illegal DMBA (AMP Citrate)". Forbes. May 6, 2015.
- "Stimulant Potentially Dangerous to Health, FDA Warns". U.S. Food and Drug Administration. April 11, 2013. Retrieved March 10, 2015.
- "DMBA in Dietary Supplements". Food and Drug Administration.
- Cohen, Pieter A.; Wen, Anita; Gerona, Roy (1 December 2018). "Prohibited Stimulants in Dietary Supplements After Enforcement Action by the US Food and Drug Administration". JAMA Internal Medicine. 178 (12): 1721–1723. doi:10.1001/jamainternmed.2018.4846. PMC 6583602. PMID 30422217.
- "Revealing the hidden dangers of dietary supplements". Science. 20 August 2015. doi:10.1126/science.aad1651.